Category Archives: Corporate

Aetna Said to Meet with DOJ on Friday about Humana Deal

Aetna Inc. (Hartford CT) executives met with top Justice Department antitrust officials on Friday to convince the government that asset sales it proposed would address potential competitive problems that could… Read more »

Medtronic Buys HeartWare for $1.1 Billion

Medtronic PLC (Dublin) said it agreed to acquire HeartWare International Inc. (Framingham MA) for $1.1 billion, adding more heart-treatment products to the giant medical-device maker. Medtronic will pay $58 a share in cash for… Read more »

U.S. Doctors, Hospitals Receive Billions from Drug, Device Makers; Report

Drug and device makers sustained their payments to doctors and teaching hospitals at nearly $6.5 billion last year, according to the figures released Thursday from a federal database. And physicians… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

Brexit Bargain Stocks Require Creative Mindset, Risk Tolerance

Frenzied bargain-hunters will immediately delve into the carnage of markets in the post-Brexit earthquake. Analysts advise caution but, more importantly, think creatively. The most obvious places to look are among… Read more »

Highmark Inc. is Seeking to Sell its Vision Unit

Highmark Inc. (Pittsburgh PA), which has lost about $773 million on the federal health insurance marketplace, is seeking to sell its vision unit, which could fetch around $2 billion. “We… Read more »

Specialty Medical Providers Envision, AmSurg to Merge

  Envision Healthcare Holdings Inc. (Greenwood Village CO) and AmSurg Corp. (Nashville TN) agreed to merge, in a deal that will create a company providing a range of hospital-related services worth some $10 billion. The… Read more »

First False Claims Act Settlement Turns on Cancer-Drug Survival Data

In the first False Claims Act settlement that turns on cancer-drug survival data, Roche Holding AG’s (Basel CHE) Genentech unit and OSI Pharmaceuticals LLC (Farmingdale NY) agreed to pay $67… Read more »